REG - Metlen Energy&Metals - Strategic Investment in Gallium Production

Metlen Energy & MetalsAnnouncement

15/05/2026 12:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260515:nRSO5668Ea&default-theme=true

RNS Number : 5668E  Metlen Energy & Metals PLC  15 May 2026

 

Ministerial Approval of Metlen's Strategic Investment in Gallium Production

London, 15 May 2026

METLEN Energy & Metals announces that the Interministerial Committee for
Strategic Investments of the Hellenic Republic has approved a new strategic
investment by the Company relating to the development of gallium production
capacity in Greece, along with the expansion of the nearby bauxite mines and
the alumina refinery.

The total investment of approximately €300 million has been designated as a
project of strategic importance in the field of critical raw materials.

Gallium is classified as a critical raw material by the European Union and is
used in a range of advanced technologies, including semiconductors, defence
applications, artificial intelligence systems and photovoltaic technologies.

The development of local production capacity is intended to support the
resilience of European industrial supply chains and reduce dependency on
external sources, in line with EU policy objectives on critical raw materials
and strategic autonomy.

The project is integrated within METLEN's existing bauxite mining and alumina
refining operations (Aluminium of Greece).

The investment has been approved under the Strategic Investments framework and
is the first project to be included under the CISAF 6.1 aid scheme, which
received European Commission approval in February 2025. The project is
expected to benefit from a combination of grants and tax incentives totalling
approximately €118 million.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCAKPBPKBKDBPD



            Copyright 2019 Regulatory News Service, all rights reserved